Interdisciplinary cardiovascular and thoracic surgery最新文献

{"title":"Fine-tuning blood culture practices: implementing diagnostic stewardship in cardiothoracic surgery patients.","authors":"Jessica Seidelman, Heather Pena, Brittany A Zwischenberger","doi":"10.1093/icvts/ivaf005","DOIUrl":"10.1093/icvts/ivaf005","url":null,"abstract":"<p><p>Overusing blood cultures (BCxs) can lead to false positives, unnecessary antibiotics and increased healthcare costs. Despite studies on inpatient BCx algorithms, none have focused on cardiothoracic surgery (CTS) patients, with complex postoperative care and invasive devices. This study aimed to evaluate the impact of a BCx algorithm on BCx event (BCE) rates in CTS step-down units. The study was conducted in three CTS step-down units at Duke University Hospital. The BCx algorithm, based on Seidelman et al. (2023), was implemented in June 2023. BCE rates, incidence rate ratios (IRRs) and adverse outcome IRRs were compared between pre- and post-intervention periods using ITS and χ2 tests. We analysed 4978 BCE during the study period: 3439 (893 patients) pre-intervention and 1539 (452 patients) post-intervention. BCE rates decreased [IRR = 0.78 (95% confidence interval (CI) 0.74, 0.83, P-value< 0.01)] without significant differences in adverse outcomes such as central line-associated bloodstream infection (CLABSI) rates (IRR = 0.6, 95% CI 0.17, 2.30), readmission rates (IRR = 0.99, 95% CI 0.88, 1.12) or in-hospital mortality (IRR = 3.53, 95% CI 0.32, 38.90). Our study supports the beneficial effects of a BCx algorithm, which reduces unnecessary BCxs in CTS patients without compromising patient safety.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11758502/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142973659","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Does methylene blue improve outcomes in patients with post-cardiac surgery vasoplegic syndrome?","authors":"Michael Z L Zhu, Jackson Scullion, Andrie Stroebel, Cheng He","doi":"10.1093/icvts/ivae221","DOIUrl":"10.1093/icvts/ivae221","url":null,"abstract":"<p><strong>Objectives: </strong>A best evidence topic was written according to a structured protocol described in ICVTS. The question addressed was 'In patients with vasoplegic syndrome following cardiac surgery with cardiopulmonary bypass, does adjunctive methylene blue improve outcomes including reduced mortality, morbidity and vasopressor requirements?'</p><p><strong>Methods: </strong>Ovid Medline was searched using a reported search algorithm. Articles that represented the best evidence to answer the clinical question were selected, tabulated and discussed.</p><p><strong>Results: </strong>Seven articles were selected: 4 randomized controlled trials and 3 observational studies. Studies were single centre with sample sizes ranging from 30 to 120 patients. Two studies reported a significant reduction in mortality among patients who received adjunctive methylene blue for post-cardiopulmonary bypass (CPB) vasoplegic syndrome compared with placebo or standard therapy. Four studies reported improved haemodynamic stability and reduced vasopressor requirements following methylene blue. No studies reported methylene blue-related adverse events or worse outcomes compared to controls or standard therapy. There was significant heterogeneity among the included studies in terms of the timing and dosage of methylene blue therapy as well as the definition of vasoplegic syndrome.</p><p><strong>Conclusions: </strong>The summation of the best available evidence, which was limited to small clinical trials and observational studies, suggests that the adjunctive administration of methylene blue for refractory post-CPB vasoplegic syndrome is safe and may provide benefits in terms of improved haemodynamic stability, reduction in vasopressor requirements and reduced mortality. Questions surrounding the optimal timing of methylene blue administration, as prophylactic, adjunctive, or rescue therapy for vasoplegic syndrome, require further investigation.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11739618/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900823","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Partial replacement of the tricuspid valve using cryopreserved tricuspid homograft: 20-year outcomes.","authors":"Samad Raza, Bishwo Shrestha, Fiona Doig, Peter Pohlner, Homayoun Jalali, Rishendran Naidoo","doi":"10.1093/icvts/ivae229","DOIUrl":"10.1093/icvts/ivae229","url":null,"abstract":"<p><strong>Objectives: </strong>There is limited consensus on the optimal strategy for surgical treatment of severe tricuspid valve pathology. At our institution, we have implemented a unique technique of using a tricuspid homograft with its supporting apparatus for partial replacement of the native tricuspid valve. We now present the long-term outcomes of these patients.</p><p><strong>Methods: </strong>We analysed a cohort of patients who underwent partial tricuspid valve replacement using tricuspid homograft. Yearly clinical and echocardiographic follow-up was performed. Fine-Gray methods were used to estimate freedom from death and reoperation and reverse Kaplan-Meier methods were used to calculate follow-up.</p><p><strong>Results: </strong>Fourteen patients were included (age range 15 days to 73 years). Indications included congenital anomalies (n = 9, 64%) and infective endocarditis (n = 5, 36%). The median follow-up was 17 years (95% confidence interval (CI) 10-21 years). Two patients (14%) died due to causes unrelated to the primary tricuspid valve surgery, and three (21%) underwent redo tricuspid valve operations. In the remaining cohort, seven (50%) were asymptomatic and two (14%) reported class II dyspnoea, while none had severe tricuspid regurgitation on echocardiogram. Estimated freedom from death was 93% at 10 years and 83% at 15 and 20 years, while estimated freedom from reoperation was 77% at 10, 15 and 20 years.</p><p><strong>Conclusions: </strong>Partial replacement of the tricuspid valve using tricuspid homograft tissue effectively restores the anatomical conformity of the native tricuspid valve and has durable long-term survival and freedom from severe tricuspid regurgitation in patients with congenital anomalies and infective endocarditis.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11723531/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142923976","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A review of nomenclature in minimally invasive coronary artery bypass grafting-the anarchy of terminology.","authors":"De Qing Görtzen, Ferdi Akca","doi":"10.1093/icvts/ivae204","DOIUrl":"10.1093/icvts/ivae204","url":null,"abstract":"<p><strong>Objectives: </strong>Since the development of minimally invasive coronary surgery, nomenclature has rapidly grown to distinguish each unique method. The goal of this review was to provide a comprehensive overview of the different terms used for minimally invasive coronary bypass grafting through the years.</p><p><strong>Methods: </strong>A literature search was performed in August 2024 using the PubMed electronic database. To extract the best search results: \"minimally invasive\" and \"coronary artery bypass grafting\" were used as either keywords or MeSH terms. The term robotic was specifically included for a second search. Eligible articles for this review were articles using an abbreviation to describe minimally invasive coronary artery bypass grafting.</p><p><strong>Results: </strong>A total of 2118 publications on non-robotic minimally invasive coronary procedures and 392 on robotic-assisted techniques were reviewed, describing 40 unique terms for the procedure. Procedures were grouped based on left internal mammary artery harvest and anastomosis methods: mini-thoracotomy for both harvesting and coronary anastomosis (n = 586), endoscopic harvest with mini-thoracotomy (n = 37), robotic harvest with mini-thoracotomy (n = 144) and closed-chest revascularization (n = 140). Minimally invasive direct coronary artery bypass grafting was the most studied technique (486 publications, non-robotic and robotic), followed by closed-chest totally endoscopic coronary artery bypass (n = 124).</p><p><strong>Conclusions: </strong>In conclusion, a wide variety of terms are used within the field of minimally invasive coronary surgery. A total of 40 different terms have been published, each describing certain specifics of the procedure. For anyone involved in the field of minimally invasive surgery, it is important to understand the differences and similarities of these procedures.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11671035/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142831020","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Mitral valve repair with the semi-rigid Memo 4D annuloplasty ring: early clinical and echocardiographic outcomes from the MANTRA study.","authors":"Omer Dzemali, Hector Rodriguez Cetina Biefer, Marco Di Eusanio, Olivier Fabre, Giovanni Troise, Nikolaos Bonaros, Francesco Grimaldi, Yeong-Hoon Choi, Giuseppe Santarpino, Cristian Baeza, Francesco Pollari, Bertrand Marcheix, Davide Pacini, Vincenzo Argano, Max Baghai, Moninder Bhabra, Enzo Mazzaro, Luigi Badano, Joerg Kempfert","doi":"10.1093/icvts/ivae208","DOIUrl":"10.1093/icvts/ivae208","url":null,"abstract":"<p><strong>Objectives: </strong>Memo 4D is a semi-rigid ring with an exclusive saddle shape and progressive increased anteroposterior diameter. This preliminary analysis reports 30-day clinical and haemodynamic outcomes of the MANTRA Memo 4D sub-study.</p><p><strong>Methods: </strong>MANTRA is an 'umbrella' prospective, multicentre, worldwide post-market study to collect real-life safety and performance data on the Corcym devices. Clinical and echocardiographic outcomes were gathered preoperatively, at discharge and each follow-up. KCCQ-12 questionnaires were collected preoperatively and at 30 days. Echocardiographic studies were performed per a predefined protocol and assessed by an independent core laboratory.</p><p><strong>Results: </strong>In total, 166 patients (52, 31.3% female, mean age 60.7 ± 11.4 years) underwent mitral valve repair with Memo 4D in 17 international institutions between July 2021 and June 2023 (enrolment is still ongoing). Primary was the most common aetiology (157, 94.6%), of which 33 cases of Barlow's disease (19.9%); secondary mitral regurgitation was present in six cases (3.6%). Thirty-day mortality was 0.6% (1). One stroke event (0.6%), one acute kidney failure (0.6%), one myocardial infarction (0.6%) and two reoperations within 30 days were reported. Surgery marked improvement in the patient's NYHA class associated with a significant increase in KCCQ-12 summary score, from 69.1 (SD = 23.7) preoperatively to 83.9 (SD = 15.7) at 30 days. End-diastolic left ventricular diameters decreased from 55.19 (SD = 7.10) preoperatively to 52.70 (SD = 3.76) mm at 30 days, and left atrial volume decreased from 125.79 (SD = 46.33) preoperatively to 91.51 (SD = 37.20) ml at 30 days. Mitral regurgitation significantly reduced after the operation and up to 30-day follow-up.</p><p><strong>Conclusions: </strong>Mitral valve repair with Memo 4D is associated with good clinical and haemodynamic outcomes in the early period.MANTRA ClinicalTrials.gov number NCT05002543.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142820301","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"A mediastinal angiomatoid fibrous histiocytoma radically resected with the use of cardiopulmonary bypass and transection of the ascending aorta.","authors":"Luis Gisli Rabelo, Christine Tolman, Brynja Jonsdottir, Tomas Gudbjartsson","doi":"10.1093/icvts/ivae214","DOIUrl":"10.1093/icvts/ivae214","url":null,"abstract":"<p><p>Angiomatoid fibrous histiocytoma (AFH) is a rare soft tissue tumour that rarely behaves malignant. We report a radical resection of a mediastinal angiomatoid fibrous histiocytoma, which grew invasively into the pulmonary artery wall, was adherent to the posterior aorta and close to the main stem of the left coronary artery. A transection of the aorta was performed using cardiopulmonary bypass and cardioplegic arrest for a safe and radical removal that resulted in symptom relief.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11681935/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142878774","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Peer coaching in cardiac surgery: a pilot study on rehabilitation participation and perioperative challenges.","authors":"Kanwar Parhar, Aaron Holm, Ravi S Hira, Lara Oyetunji, Jeannie Collins-Brandon, Eric J Lehr, Sarah Speck","doi":"10.1093/icvts/ivae219","DOIUrl":"10.1093/icvts/ivae219","url":null,"abstract":"<p><p>Following cardiac surgery, active participation in cardiac rehabilitation (CR) is associated with reduced cardiovascular events and improved survival. However, CR attendance remains persistently low, with only ∼25% of patients participating. The Peer Coaching for Cardiac Patients (PCCP) pilot programme aimed to assess whether peer coaching could enhance CR participation and reduce perioperative anxiety and depression in cardiac surgery patients. Ten patients scheduled for elective cardiac surgery were enrolled, receiving 4 60-min coaching sessions via Zoom, by a coach who had undergone coronary artery bypass grafting in the past. Outcomes were measured by CR participation rates, Patient Health Questionnaire (PHQ)-9 scores, and a post-programme survey. Seven of the 10 patients completed the PCCP programme, all of which attended CR for an average of 19.3 ± 8.70 sessions and 9.57 ± 3.0 weeks. No statistically significant difference in PHQ-9 scores was observed (P = 0.341). Participants rated the programme highly in its role in anxiety reduction (9.0 ± 1.2) and likelihood of participating in CR (9.43 ± 1.05). These results suggests that peer coaching shows potential to support CR participation and address perioperative anxiety and depression. Future studies with larger sample sizes, well-defined control groups and extended follow-up are warranted to validate these preliminary findings.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11717349/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900887","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Surgical indications for pleurectomy/decortication in pleural mesothelioma based on the newly revised 9th edition of the tumour-node-metastasis classification.","authors":"Masatoshi Kanayama, Masaru Takenaka, Takehiko Manabe, Katsuma Yoshimatsu, Rintaro Oyama, Hiroki Matsumiya, Masataka Mori, Koji Kuroda, Fumihiro Tanaka","doi":"10.1093/icvts/ivae223","DOIUrl":"10.1093/icvts/ivae223","url":null,"abstract":"<p><strong>Objectives: </strong>The MARS2 trial questioned the efficacy of curative intent surgery for pleural mesothelioma (PM), while real-world clinical data from Japan suggest a favourable prognosis in surgical cases, indicating survival benefits in selected patients. The newly revised 9th edition of the tumour-node-metastasis (TNM) classification introduces a novel indicator based on pleural thickness.</p><p><strong>Methods: </strong>We conducted a retrospective evaluation of patients with PM who underwent pleurectomy/decortication between 2012 and 2022. Patient characteristics, complications and treatment outcomes were assessed. Additionally, outcomes were analysed based on the 9th edition of the TNM classification.</p><p><strong>Results: </strong>A total of 62 patients were included in the analysis. The median overall survival (OS) was 37.3 months, with a median relapse-free survival (RFS) of 15.5 months. Patients with the epithelioid subtype (OS: 61.6 months; RFS: 26.0 months) and pStage IA (OS: not reached; RFS: 69.1 months) had significantly better outcomes. The 9th edition of the TNM classification showed a stronger prognostic correlation than the 8th edition, with a median OS of 77.0, 31.9, 20.4 and 25.3 months for stages I, II, IIIA and IIIB (P = 0.0016) and median RFS of 34.3, 12.3, 13.7 and 6.9 months for stages I, II, IIIA and IIIB (P = 0.013), respectively.</p><p><strong>Conclusions: </strong>Surgical intervention remains crucial in the treatment of PM, particularly for patients with epithelioid histology and early stages of the disease. This study evaluates surgical indications for PM using the newly revised 9th edition of the TNM classification, indicating that it enhances the precision of surgical candidate selection and potentially improves patient outcomes.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742126/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142900893","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Assessment of the financial gaps in cardiothoracic surgery in Africa.","authors":"Cynthia Nwalibe, Victory Bassey Effiom, Achanga Bill-Smith Anyinkeng, Michael Anayo James, Eben-Ezer Genda, Wambui Irungu, Frank-Awat Abaiweh, Kelechi E Okonta","doi":"10.1093/icvts/ivae228","DOIUrl":"10.1093/icvts/ivae228","url":null,"abstract":"<p><strong>Objectives: </strong>This study identified the challenges to financing cardiothoracic surgical care in Africa, highlighting the present state of funding and proffering probable solutions to adequate and effective funding in the region.</p><p><strong>Methods: </strong>In a literature review, the authors elaborated key points, such as areas of financial funding in cardiothoracic surgery; barriers to appropriate allocation of financial resources for cardiothoracic surgery in Africa; and the needs and available resources for cardiothoracic surgery in Africa. Multiple search engines and databases were used, including but not limited to PubMed, Medline, Cochrane, Scopus and Google Scholar. Sixty articles were identified, and 50 of the 60 were used for this review.</p><p><strong>Results: </strong>Operations to treat cardiovascular and thoracic diseases performed on the African continent are known to be expensive. They also tend to result in significant morbidity and mortality among the affected individuals because payment is largely out of pocket and the coverage by health insurance providers is low. The establishment of cardiothoracic surgical centres and the delivery of cardiothoracic surgical care are expensive endeavours that limit access to care of patients without comprehensive health insurance or philanthropic support. These poor outcomes are attributed mainly to inadequate funding.</p><p><strong>Conclusions: </strong>We therefore have recommended advocating for increased funding and for support of policies designed to support the prioritization of cardiothoracic care within national and regional healthcare agendas in order to include cardiothoracic surgery in global and national healthcare plans. Non-governmental organizations and major industries (foreign and local) should be encouraged to invest substantial funds in building and developing cardiothoracic surgery centres in Africa.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC11742124/pdf/","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142959903","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

{"title":"Endovascular therapy and minimally invasive coronary artery bypass grafting for Leriche syndrome with ischaemic heart disease.","authors":"Hiroki Moriuchi, Mamoru Orii, Nobuhiro Shimabukuro, Akihiko Yamauchi","doi":"10.1093/icvts/ivaf008","DOIUrl":"10.1093/icvts/ivaf008","url":null,"abstract":"<p><p>In patients with Leriche syndrome and coronary artery disease, the operative strategy is very important because the internal thoracic artery often provides important collateral blood flow to the lower extremities. A 65-year-old man with diabetes mellitus was admitted with heart failure and bilateral claudication. We successfully performed endovascular therapy for aortoiliac occlusive disease, followed by minimally invasive coronary artery bypass grafting for ischaemic heart disease. Postoperative course was uneventful. This is the first report of using minimally invasive coronary artery bypass grafting and endovascular therapy to treat Leriche syndrome with ischaemic heart disease.</p>","PeriodicalId":73406,"journal":{"name":"Interdisciplinary cardiovascular and thoracic surgery","volume":" ","pages":""},"PeriodicalIF":0.0,"publicationDate":"2024-12-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"143025812","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}